R
Richard E. Champlin
Researcher at University of Texas MD Anderson Cancer Center
Publications - 1500
Citations - 73470
Richard E. Champlin is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 138, co-authored 1402 publications receiving 66917 citations.
Papers
More filters
Journal ArticleDOI
Viral Reactivation in Haploidentical Transplants Using Post-Transplantation Cyclophosphamide – a Single Institution Experience
Reshma Ramlal,Koji Sasaki,Sara Lozano Cerrada,Samer A. Srour,Julianne Chen,R. Gabriella Rondon,Katy Rezvani,Betul Oran,Amanda Olson,Elizabeth J. Shpall,Richard E. Champlin,Stefan O. Ciurea +11 more
Journal ArticleDOI
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
Brittany Knick Ragon,Rohtesh S. Mehta,Alison M. Gulbis,Rima M. Saliba,Julianne Chen,Gabriela Rondon,Uday R. Popat,Yago Nieto,Betul Oran,Amanda Olson,Krina K. Patel,Chitra Hosing,Muzaffar H. Qazilbash,Nina Shah,Partow Kebriaei,Elizabeth J. Shpall,Richard E. Champlin,Amin M. Alousi +17 more
TL;DR: Pentostatin remains a viable treatment option for steroid-refractory (SR)-aGVHD, especially in patients 60 years or younger with isolated LGI involvement, and in patients <60 years witholated LGI GVHD with isolatedLGI involvement.
Journal ArticleDOI
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Rima M. Saliba,Krishna V. Komanduri,Sergio Giralt,J. de Souza,Poliana A. Patah,Betul Oran,Daniel R. Couriel,Gabriela Rondon,Richard E. Champlin,M. de Lima +9 more
TL;DR: The data showed that the presence of circulating blasts before transplantation is significantly correlated with low post-SCT day +30 ALC and slow platelet engraftment, suggesting that the impact of early A LC and platelet recovery on transplant outcome may not be independent of disease status at transplantation.
Journal ArticleDOI
Principles of bone marrow processing and progenitor cell/mononuclear cell concentrate collection in a continuous flow blood cell separation system.
Jeane P. Hester,Gabriela Rondon,Yang O. Huh,M. J. Lauppe,Richard E. Champlin,Albert B. Deisseroth +5 more
TL;DR: A protocol for recovery of MNC, CD33+, CD34+, and CD34+/DR- cells from harvested marrow for autologous and allogeneic transplants using a continuous flow blood cell separator is developed, the variables influencing the recovery of the cells of interest and the clinical response to infusion of the processed cells are reported.
Journal ArticleDOI
Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia
Rupin A Shah,Satyajit Mohite,Veerabhadran Baladandayuthapani,Sheeba K. Thomas,Donna M. Weber,Michael Wang,Raymond Alexanian,Muzaffar H. Qazilbash,Uday R. Popat,Richard E. Champlin,Nina Shah,Qaiser Bashir,Simrit Parmar,Yago Nieto,Sairah Ahmed,Robert Z. Orlowski,Jatin J. Shah +16 more
TL;DR: The overall survival of patients with any CPC observed on routine complete blood count (CBC) and differential with those that meet the WHO criteria of PCL was compared and results were identical.